Endo Pharmaceuticals Down 11.7% Since SmarTrend Downtrend Call (ENDP)

SmarTrend identified a Downtrend for Endo Pharmaceuticals (NASDAQ:ENDP) on September 24th, 2015 at $72.77. In approximately 2 weeks, Endo Pharmaceuticals has returned 11.71% as of today's recent price of...